The paper reports that changes to NICE's existing appraisal system will see the Institute evolve its current methods to also take account of the wider societal benefits alongside the cost and clinical benefits of a medication.
The Telegraph then wrongly speculates that this will result in older patients missing out on treatments because they do not contribute as much to society as younger people.
Here we take a closer look at the story. NICE
No comments:
Post a Comment